Netherlands· NL-f59d84985d79

QUADRAMET, oplossing voor injectie 1,3 GBq/ml

A samarium (153sm) lexidronam product containing samarium (153sm) lexidronam pentanatrium, registered in Netherlands by Cis Bio International. The same ATC class is registered in 8 of our 19 countries.

ATC V10BX02

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about samarium (153sm) lexidronam pentanatriumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Samarium (153sm) lexidronam is registered in 8 of 19 countries.

Countries holding a registration under ATC V10BX02 (samarium (153sm) lexidronam), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
5 of them publish a price we can compare per daily dose

Search samarium (153sm) lexidronam products by name

Samarium (153sm) lexidronam · ATC V10BX02

8 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Polandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: SAMARIUM (153SM) LEXIDRONAM PENTANATRIUM
Manufacturer: Cis Bio International
Country: Netherlands (NL)
ATC code: V10BX02
ATC class: Samarium (153Sm) lexidronam
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/97/057

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Samarium (153sm) lexidronam in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All samarium (153sm) lexidronam products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/df624a5a-932f-4c67-87a3-651fdbf829da
GET /v1/drugs/df624a5a-932f-4c67-87a3-651fdbf829da?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/quadramet-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Samarium (153 Sm) Lexidronam",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp70155",
  "excipients": [
    "CALCIUMHYDROXIDE (E 526)",
    "LEXIDRONAM 1-WATER",
    "NATRIUMHYDROXIDE (E 524)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "SAMARIUM (153SM) LEXIDRONAM PENTANATRIUM"
  ],
  "leaflet_url": null,
  "authorised_at": "1998/02/05",
  "procedure_number": "EMEA/H/C/000150",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/97/057",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about samarium (153sm) lexidronam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console